Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
OpenAI Nears Astra AI Model Launch With Safety Focus 
Xiaomi Shares Jump on Europe EV Expansion Plan 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Volkswagen Approves 50,000 More Job Cuts in Major Restructuring 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
Milei Threatens Falkland Oil Firms With Sanctions 
Lynas Rare Earths Shares Rise After Takeover Talks Revealed 
CATL Shares Fall as Hungary Plant Faces Safety Halt 
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
OpenAI Rejects Apple Trade Secret Theft Claims 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
Add as a preferred source on Google
SOUTH SAN FRANCISCO, Calif., March 05, 2018 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the following investor conferences in March 2018:
- Cowen and Company 38th Annual Health Care Conference in Boston on March 12 at 11:20 a.m. Eastern Time (ET);
- 28th Annual Oppenheimer Healthcare Conference in New York City on March 20 at 10:55 a.m. ET; and
- 17th Annual Needham Healthcare Conference in New York City on March 27 at 11:30 a.m. ET.
The presentations will be webcast live and available for replay from GBT’s website at www.gbt.com in the Investors section.
About GBT
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.
Contact Information:
Myesha Lacy (investors)
GBT
650-351-4730
[email protected]
Julie Normart (media)
W2Opure
415-946-1087
[email protected]
